Abstract:Purpose To retrospectively evaluate the safety and efficacy of percutaneous computed tomography (CT)-guided microwave ablation (MWA) in colorectal cancer (CRC) lung metastases, and to analyze prognostic factors. Materials and methods Data were collected from 31 patients with CRC lung metastases from May 2013 to September 2017. They had removed the CRC, no extrapulmonary metastases, no more than three metastases in the lung, the maximum diameter of the lesions was ≤3 cm, and all the lung metastases could be completely ablated. The ablation procedures were performed using a KY-2000 microwave multifunctional therapeutic apparatus. Efficacy is assessed two to four weeks after ablation, and follow-up are performed every three months for two years. The primary outcome was overall survival (OS). The secondary outcomes were progression-free survival (PFS), and complications. Cox regression analysis was used for the evaluation of the statistical significance of factors affecting the end result of MWA therapy. The Kaplan–Meier method was used for estimation of survival rates. Results A total of 45 metastatic lung lesions from CRC in 31 patients were treated with CT-guided MWA procedures. The median OS was 76 months. The one, two, three, and five-year survival rates were 93.5%, 80.6%, 61.3%, and 51.6%, respectively. Multivariate analysis showed that the primary tumor from the rectum ( P = 0.009) and liver metastases at the diagnosis of lung metastases ( P = 0.043) were risk factors affecting OS, while PFS was a protective factor. The median PFS was 13 months. The maximum diameter of lung metastases lesions ( P = 0.004) was a risk factor. The interval between pulmonary metastases and MWA ( P =0.031) was the protective factor. Pneumothorax was observed in 13 out of 36 procedures. Four patients developed pneumothorax requiring drainage tube insertion. No patient deaths occurred within 30 days of ablation. Three out of 31 patients (9.67%) were found to have local recurrence of the original lung metastatic ablation foci. Conclusion MWA therapy may be safely and effectively used as a therapeutic tool for the treatment of selected CRC pulmonary metastases, and the prognosis is better in patients without liver metastases at the diagnosis of lung metastases.

The efficacy and complications of computed tomography guided microwave ablation in lung cancer

Efficacy and Potential MicroRNA Mechanism for Computed Tomography-Guided Percutaneous Radiofrequency Ablation of Primary Lung Cancer and Lung Metastasis from Liver Cancer

Safety and Effectiveness Analysis of Percutaneous Microwave Thermal Ablation Therapy Combined Brachytherapy for Lung Malignant Lesion

Study on Ultrasound-guided Percutaneous Microwave Ablation and Surgical Resection for Papillary Thyroid Microcarcinoma

CT‐guided Microwave Ablation in Patients with Lung Metastases from Breast Cancer

Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity–Lung adenocarcinoma: A pilot study

Microwave Ablation for Lung Cancer Patients with a Single Lung: Clinical Evaluation of 11 Cases

Computed tomography-guided percutaneous microwave ablation of early stage non-small cell lung cancer in a pneumonectomy patient.

Major Complications After Lung Microwave Ablation: A Single-Center Experience on 204 Sessions

Efficacy and Safety of Microwave Ablation in the Treatment of Patients with Oligometastatic Non-Small-cell Lung Cancer: a Retrospective Study.

Long-term outcome following microwave ablation of lung metastases from colorectal cancer

Safety and local efficacy of computed tomography-guided microwave ablation for treating early-stage non-small cell lung cancer adjacent to bronchovascular bundles

Microwave ablation therapy assisted by artificial pneumothorax and artificial hydrothorax for lung cancer adjacent to the vital organs

A Feasibility and Safety Study of Computed Tomography-Guided Percutaneous Microwave Ablation: a Novel Therapy for Multiple Synchronous Ground-Glass Opacities of the Lung

Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study

Retrospective cohort study on the correlation analysis among peri-procedural factors, complications, and local tumor progression of lung tumors treated with CT-guided microwave ablation

Therapeutic Effect of CT-guided 125I Seed Implantation on Advanced Lung Cancer and Pulmonary Metastatic Carcinoma

A Study of Microwave Ablation for Small Cell Lung Cancer.

Safety and Clinical Outcomes of Computed Tomography‐guided Percutaneous Microwave Ablation in Patients Aged 80 Years and Older with Early‐stage Non‐small Cell Lung Cancer: A Multicenter Retrospective Study

Microwave ablation versus radiofrequency ablation for the treatment of pulmonary tumors

Percutaneous Microwave Ablation of Stage I Medically Inoperable Non‐small Cell Lung Cancer: Clinical Evaluation of 47 Cases